(Q34319721)

1 August 2017

1 reference

title

Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic (English)

1 reference

1 August 2017

0 references

1 reference

3

1 reference

1 August 2017

Rissanen TT

1

1 reference

1 August 2017

Vajanto I

series ordinal

2

1 reference

1 August 2017

publication date

1 August 2001

1 reference

European Journal of Clinical Investigation

1 August 2017

published in

1 reference

1 August 2017

volume

31

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

651-666

1 reference

The prevalence of peripheral arterial disease in a defined population

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Exercise therapy for intermittent claudication: a review of the quality of randomised clinical trials and evaluation of predictive factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Cardiovascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Clinical applications of vascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Molecular mechanisms of coronary collateral vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Age-dependent impairment of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Estrogen and angiogenesis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Signaling via vascular endothelial growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Control of hair growth and follicle size by VEGF-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Receptor specificity of the fibroblast growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Fibroblast growth factor receptors (FGFRs) and their roles in limb development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Detection of spatial localization of Hst-1/Fgf-4 gene expression in brain and testis from adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Muscle regeneration: molecular aspects and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

PDGF mediates cardiac microvascular communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

The role of PDGF-BB on the development of the collateral circulation after acute arterial occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Tissue repair with a therapeutic transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Enhanced plasma cholesterol lowering effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and stimulation of hepatocyte proliferation by combined partial liver resection and thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Lentiviral vectors and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Evaluation of recombinant alphaviruses as vectors in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Muscle maturation: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Virus treatment questioned after gene therapy death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Effective repeat administration with adenovirus vectors to the muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Gene transfer in regenerating muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

The efficient expression of intravascularly delivered DNA in rat muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Inflammatory responses following direct injection of plasmid DNA into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Immune responses, not promoter inactivation, are responsible for decreased long-term expression following plasmid gene transfer into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Enhanced revascularization of the ischemic limb by angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Angiogenic therapy for the chronically ischemic lower limb in a rabbit model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

bFGF enhances the development of the collateral circulation after acute arterial occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Induction of angiogenesis by lidocaine and basic fibroblast growth factor: a model for in vivo retroviral-mediated gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Adenoviral gene transfer of basic fibroblast growth factor promotes angiogenesis in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2001.00864.X

10.1046/J.1365-2362.2001.00864.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference